Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  MEDNAX Inc    MD

Delayed Quote. Delayed  - 05/27 10:02:01 pm
68.08 USD   +0.73%
05/28 MEDNAX : Shady Grove Medical Center Neonatology Team Wins Quality an..
05/27 MEDNAX : Shady Grove Medical Center Neonatology Team Wins Quality an..
05/26 MEDNAX : to Present and Exhibit at the 2016 Advanced Institute for A..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in  $ Estimates in  $
Fiscal Period December 201320142015201620172018
Sales2 1542 439-3 1413 4303 816
Operating income (EBITDA)492559654690754818
Operating profit (EBIT)452513632603668761
Pre-Tax Profit (EBT)448-----
Net income281317-348386435
P/E ratio19,220,820,018,216,414,8
EPS ( $ )2,783,183,583,734,154,60
Dividend per Share ( $ )------
Yield------
Reference price ( $ )53.3866.1171.6668.0868.0868.08
Announcement Date01/30/2014
11:00am
01/29/2015
11:00am
----
Finances - Leverage
Actuals in  $ Estimates in  $
Fiscal Period December 201320142015201620172018
Debt-515-1 129962-
Finance10,4-----
Operating income (EBITDA)492559654690754818
Leverage
(Debt/EBITDA)
-0,92x-1,64x1,28x-
Capital Expenditure15,618,127,136,530,835,0
Book Value Per Share (BVPS)23,2 $22,6 $25,9 $29,2 $32,3 $34,8 $
Cash Flow per Share4,02 $4,23 $3,92 $5,32 $5,66 $5,80 $
Announcement Date01/30/2014
11:00am
01/29/2015
11:00am
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 6 326 M$ -
Entreprise Value (EV) 7 454 M$ 7 288 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 18,2x 16,4x
Capitalization / Revenue 2,01x 1,84x
EV / Revenue 2,37x 2,12x
EV / EBITDA 10,8x 9,66x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 2,34x 2,11x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 19,2% 19,5%
operating Leverage (Delta EBIT / Delta Sales) - 1,18x
Net Margin (Net Profit / Revenue) 11,1% 11,3%
ROA (Net Profit / Asset) 7,40% 7,60%
ROE (Net Profit / Equities) 14,0% 13,8%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   1,16% 0,90%
Cash Flow / Sales 15,7% 15,3%
Capital Intensity (Assets / Sales) 1,50x 1,48x
Financial Leverage (Net Debt / EBITDA) 1,64x 1,28x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend